New tool makes gene regulation easier to study—and tweak

Leuven, 2 April 2026 - Understanding how genes are switched on and off in specific cell types remains one of biology’s central challenges. While AI has made major progress in decoding the regulatory logic of DNA, applying these approaches across datasets, tissues, and species has remained difficult. In a new Nature Methods paper, a research team led by Prof. Stein Aerts (VIB & KU Leuven) presents CREsted, a software package that enables both the analysis and design of gene regulatory elements in a systematic and scalable way.

Enhancers are gene regulatory elements—short DNA sequences that control when and where genes are active. Deep learning models can help decode this “regulatory code”, but existing approaches are often tailored to one dataset or one task, making them hard to reuse or extend.

To address this, Prof. Stein Aerts and his team developed CREsted, a new framework that turns enhancer modeling from a collection of one-off analyses into a more systematic and reusable workflow.

“We wanted to move beyond one-off models,” says Niklas Kempynck, PhD student in the Aerts lab. “CREsted allows researchers to systematically study enhancer logic across biological systems, starting from cell-by-cell maps of accessible regulatory DNA and going all the way to sequence design.”

CREsted brings together several steps that are usually handled separately: preprocessing, model training, interpretation, and synthetic enhancer design. It is also built to fit into existing single-cell analysis workflows, making it easier for researchers to adopt and use.

Prof. Stein Aerts, Dr. Seppe De Winter, and Niklas Kempynck
Prof. Stein Aerts, Dr. Seppe De Winter, and Niklas Kempynck
“With CREsted, we give researchers a complete workflow,” says Dr. Seppe De Winter, who shares first authorship with Kempynck. “You can train deep learning models on chromatin accessibility data, interpret which regulatory features they capture, and then use those models to design new DNA sequences with predicted cell-type-specific activity.”

To show its versatility, the team applied CREsted to multiple systems, including mouse brain tissue, human immune cells, cancer cell states, and zebrafish development. Across these settings, the framework identified regulatory patterns, predicted enhancer activity, and enabled the design of synthetic enhancers, which were validated in vivo in zebrafish.

For Prof. Stein Aerts, Scientific Director of VIB.AI, the strength of CREsted lies in making a powerful development more coherent and reusable.

“CREsted makes it much easier to train, interpret, and compare enhancer models across datasets,” he says. “That is important if we want these approaches to become broadly useful, not just for understanding regulatory DNA, but also for designing and testing new sequences in a systematic way.”

Taken together, the work shows how AI can help move the field from describing regulatory DNA to actively exploring and designing it. With applications ranging from fundamental biology to biotechnology and medicine, CREsted lays the groundwork for more systematic and programmable control of gene regulation.


Publication

CREsted: modeling genomic and synthetic cell type-specific enhancers across tissues and species. Kempynck, De Winter et al. Nature Methods, 2026. DOI: https://doi.org/10.1038/s41592-026-03057-2 ​

Funding

This research was funded in part by Aligning Science Across Parkinson’s through the Michael J. Fox Foundation for Parkinson’s Research (MJFF); the European Research Council, the Chan-Zuckerberg Initiative, the Research Foundation Flanders - FWO, and the Foundation Against Cancer. For all funders, see the paper’s acknowledgements.

 

Share

Latest stories

Researchers discover clues for Alzheimer’s disease in hibernation

Researchers discover clues for Alzheimer’s disease in hibernation

Leuven, 12 November 2026 – Researchers at VIB and KU Leuven have discovered that hibernation triggers changes in brain cells that partially resemble those in Alzheimer’s disease. Studying golden hamsters, the team identified changes in gene expression across the hibernation cycle, which resemble those associated with the accumulation of amyloid plaques in Alzheimer’s. The findings, published in Science Advances, suggest that some early cellular changes associated with Alzheimer’s may also occur as part of a natural adaptive response, offering new ways to study the disease for therapy development.

press.vib.be

An inside look at a molecular switch that triggers inflammation

An inside look at a molecular switch that triggers inflammation

Ghent, 9 November 2026 – Researchers at VIB and Ghent University have uncovered how an important driver of inflammation is activated at the molecular level. Their findings, published in Science Immunology, also explain how a medicine used to treat a severe form of psoriasis blocks this inflammatory signal.

press.vib.be

Researchers uncover why humans are more sensitive than other species to a brain developmental disease

Researchers uncover why humans are more sensitive than other species to a brain developmental disease

Leuven, 4 November 2026 – Researchers at VIB and KU Leuven have uncovered how mutations in the ASPM gene disrupt the development of neural stem cells that help the human brain grow. This disruption explains how these mutations cause microcephaly, a condition characterized by an abnormally small brain and head, often accompanied by intellectual disability. The discovery, published in Developmental Cell, also sheds light on how differences in brain development can make humans more susceptible to certain genetic conditions than other mammals.

press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be